In the first half of 2017, the CHIPSCREEN BIOSCIENCES tumor division held 2017 HDACi regional summits in Kunming, Hangzhou, Guangzhou and Beijing respectively, with a view to preheating the national summit at the end of the year.

The chairmen and speakers invited at the regional summit are well-known experts in the industry who have already gained considerable experience in the clinical application of Chidamide. The reports and case analysis of these speakers provide strong support for other experts in the clinical treatment of PTCL and other blood tumors in the future.

Through four regional summits, Chidamide, the innovative medicine of CHIPSCREEN BIOSCIENCES, has once again deepened the knowledge category of experts and their understanding of epigenetic inheritance. The experts of the entire meeting responded enthusiastically with discussions and exchanges. The summit was a complete success.